In a recent panel discussion, life sciences compliance leaders addressed the evolving regulatory landscape in Latin America with insightful strategies to mitigate third-party risks and logistics vulnerabilities. The discussion focused on the intersection of the FCPA (Foreign Corrupt Practices Act) and the practical challenges of maintaining business continuity in high-risk regions. New Federal Policies and […] The post Life Sciences Compliance: Navigating Evolving Supply Chain Risk in Latin America appeared first on Dow Jones .